Tuesday, November 4, 2025

Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Powerhouse

Kimberly-Clark Corporation (NASDAQ: KMB) has announced its acquisition of Kenvue Inc. (NYSE: KVUE), marking a new chapter in the global health and consumer goods industry. The merger will create a combined company with annual revenues of approximately $32 billion and a portfolio of ten billion-dollar brands that reach nearly half of the world’s population.

The purchase price of $48.7 billion consists of cash and stock, offering Kenvue shareholders both immediate value and long-term participation in the combined company’s growth. With expected synergies of $2.1 billion and earnings accretion by year two, the deal represents a strong strategic and financial move.

“We are bringing together two iconic companies to create a global leader in health and wellness,” said Mike Hsu, CEO of Kimberly-Clark. Kenvue, with brands such as Neutrogena, Listerine, Tylenol, and Johnson’s, will join forces with Kimberly-Clark’s powerful lineup, including Huggies, Kleenex, and Kotex.

The combination will drive new innovation potential through enhanced investment in marketing, research, and development, while Kimberly-Clark’s proven commercial execution playbook will strengthen the company’s presence in key growth markets.

According to both companies, the merger is expected to close in the second half of 2026, pending shareholder and regulatory approvals. The combined company will remain headquartered in Irving, Texas, while maintaining a strong presence at Kenvue’s existing sites.

This acquisition is not only one of the largest in consumer goods history, but also a clear signal of a growing focus on health, science, and sustainable innovation.